+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Excipients for Taste Masking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 175 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5918336
The pharmaceutical industry is witnessing a significant shift in the use of excipients for taste masking, and the global market is on an upward trajectory. According to recent research, the Pharmaceutical Excipients for Taste Masking Market generated approximately US$ 960 Million in revenue in 2024, and it is projected to reach a valuation of around US$ 1400 Million by the end of 2031.

Taste Masking for Enhanced Patient Experience

Taste masking procedures are essential for enhancing the patient experience when it comes to oral medications. Medications such as antibiotics, anti-inflammatory drugs, and analgesics often have a bitter or unpleasant taste, making it challenging to administer them to geriatric and pediatric patient populations. Taste masking techniques are designed to address this issue, ensuring that patients can take their medications without discomfort.

Evolution in Taste Masking Approaches

Over the years, taste masking techniques have evolved significantly. In the early 1990s, sweeteners were commonly used to mask the taste of medications. However, using sweeteners alone proved ineffective for water-soluble medications administered in high amounts. Subsequently, coating as a taste masking method gained acceptance, leading to numerous patents in pharmaceutical excipients for taste masking. In recent years, granulation has become increasingly popular. These technological advancements are expected to drive the growth of the pharmaceutical excipients for taste masking market in the coming years.

Driving Factors for Market Growth

One of the primary drivers of market growth is the increasing demand for medicines. The taste and odor of any substance play a critical role in its acceptance, especially when it comes to medications with bitter tastes. Pharmaceutical excipients for taste masking are instrumental in providing a pleasant taste to final drug formulations, potentially reducing drug-induced nausea.

The use of various excipients for sweetening, ranging from synthetic to natural, has provided manufacturers with cost-effective and accessible options, enhancing their competitiveness in the pharmaceutical excipients for taste masking market.

Challenges on the Horizon

Despite the promising growth prospects, the pharmaceutical excipients for taste masking market faces challenges in the form of increasing regulatory stringency for drug and excipient approval. Regulatory authorities are placing greater emphasis on controlling the manufacturing and distribution of excipients to ensure patient safety. Compliance with quality standards and supply chain integrity is essential, and these regulatory requirements may limit the market's expansion.

Regional Market Dynamics

  • United States: The United States market is booming due to the rapidly expanding pharmaceutical sector, rising demand for functional excipients, the presence of significant competitors, and technological advancements.
  • Germany: Germany is expected to be a lucrative market, driven by the increasing prevalence of chronic diseases, substantial investments by pharmaceutical companies, and the adoption of emerging technologies such as nanotechnology.
  • China: China is emerging as a prominent market, with chitosan-based taste masking techniques gaining traction in traditional Chinese medicine. This method is effectively improving the taste of bitter drugs used in traditional Chinese medicine.

Competitive Landscape

Key players in the pharmaceutical excipients for taste masking market are focused on expanding their market share by developing new platforms and innovative taste masking technologies. These include stimuli-responsive drug delivery systems that use pH- and ion-sensitive polymers to mask the bitter taste of medicines.

Key Companies Covered:

  • Roquette Frères
  • Rochem International, Inc.
  • Gattefose
  • Asahi Kasei Corporation
  • DuPont de Nemours, Inc
  • Dow Pharma Solutions
  • SPI Pharma, Inc
  • GPT Pharmaceuticals Pvt. Ltd
  • Adare Pharmaceuticals Inc.

Market Segmentation

Excipient:

  • Natural
  • Artificial
  • Nutritive
  • Non- nutritive
  • Polyols
  • Others

Technique:

  • Hot Melt Extrusion
  • Microencapsulation
  • Coating
  • Organoleptic Methods
  • Others

Usage:

  • Solid Dosage Forms
  • Tablets
  • Granules
  • Capsules
  • Liquid Dosage Forms

End-User:

  • Pharmaceuticals
  • Nutraceuticals
  • Contract Manufacturing Organizations

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Pharmaceutical Excipients for Taste Masking Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Pharmaceutical Excipients for Taste Masking Market Outlook, 2018 - 2031
3.1. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Natural
3.1.1.2. Artificial
3.1.1.3. Nutritive
3.1.1.4. Non- nutritive
3.1.1.5. Polyols
3.1.1.6. Others
3.2. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hot Melt Extrusion
3.2.1.2. Microencapsulation
3.2.1.3. Coating
3.2.1.4. Organoleptic Methods
3.2.1.5. Others
3.3. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Solid Dosage Forms
3.3.1.1.1. Tablets
3.3.1.1.2. Granules
3.3.1.1.3. Capsules
3.3.1.2. Liquid Dosage Forms
3.4. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Pharmaceuticals
3.4.1.2. Nutraceuticals
3.4.1.3. Contract Manufacturing Organizations
3.5. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Pharmaceutical Excipients for Taste Masking Market Outlook, 2018 - 2031
4.1. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Natural
4.1.1.2. Artificial
4.1.1.3. Nutritive
4.1.1.4. Non- nutritive
4.1.1.5. Polyols
4.1.1.6. Others
4.2. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hot Melt Extrusion
4.2.1.2. Microencapsulation
4.2.1.3. Coating
4.2.1.4. Organoleptic Methods
4.2.1.5. Others
4.3. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Solid Dosage Forms
4.3.1.1.1. Tablets
4.3.1.1.2. Granules
4.3.1.1.3. Capsules
4.3.1.2. Liquid Dosage Forms
4.4. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Pharmaceuticals
4.4.1.2. Nutraceuticals
4.4.1.3. Contract Manufacturing Organizations
4.5. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
4.5.1.2. U.S. Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
4.5.1.3. U.S. Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
4.5.1.4. U.S. Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
4.5.1.5. Canada Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
4.5.1.6. Canada Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
4.5.1.7. Canada Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
4.5.1.8. Canada Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, 2018 - 2031
5.1. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Natural
5.1.1.2. Artificial
5.1.1.3. Nutritive
5.1.1.4. Non- nutritive
5.1.1.5. Polyols
5.1.1.6. Others
5.2. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hot Melt Extrusion
5.2.1.2. Microencapsulation
5.2.1.3. Coating
5.2.1.4. Organoleptic Methods
5.2.1.5. Others
5.3. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Solid Dosage Forms
5.3.1.1.1. Tablets
5.3.1.1.2. Granules
5.3.1.1.3. Capsules
5.3.1.2. Liquid Dosage Forms
5.4. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Pharmaceuticals
5.4.1.2. Nutraceuticals
5.4.1.3. Contract Manufacturing Organizations
5.5. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
5.5.1.2. Germany Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
5.5.1.3. Germany Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
5.5.1.4. Germany Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.5. U.K. Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
5.5.1.6. U.K. Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
5.5.1.7. U.K. Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
5.5.1.8. U.K. Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.9. France Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
5.5.1.10. France Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
5.5.1.11. France Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
5.5.1.12. France Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.13. Italy Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
5.5.1.14. Italy Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
5.5.1.15. Italy Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
5.5.1.16. Italy Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.17. Turkey Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
5.5.1.18. Turkey Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
5.5.1.19. Turkey Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
5.5.1.20. Turkey Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.21. Russia Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
5.5.1.22. Russia Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
5.5.1.23. Russia Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
5.5.1.24. Russia Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.25. Rest of Europe Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
5.5.1.26. Rest of Europe Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
5.5.1.27. Rest of Europe Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
5.5.1.28. Rest of Europe Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, 2018 - 2031
6.1. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Natural
6.1.1.2. Artificial
6.1.1.3. Nutritive
6.1.1.4. Non- nutritive
6.1.1.5. Polyols
6.1.1.6. Others
6.2. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hot Melt Extrusion
6.2.1.2. Microencapsulation
6.2.1.3. Coating
6.2.1.4. Organoleptic Methods
6.2.1.5. Others
6.3. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Solid Dosage Forms
6.3.1.1.1. Tablets
6.3.1.1.2. Granules
6.3.1.1.3. Capsules
6.3.1.2. Liquid Dosage Forms
6.4. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Pharmaceuticals
6.4.1.2. Nutraceuticals
6.4.1.3. Contract Manufacturing Organizations
6.5. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
6.5.1.2. China Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
6.5.1.3. China Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
6.5.1.4. China Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.5. Japan Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
6.5.1.6. Japan Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
6.5.1.7. Japan Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
6.5.1.8. Japan Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.9. South Korea Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
6.5.1.10. South Korea Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
6.5.1.11. South Korea Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
6.5.1.12. South Korea Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.13. India Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
6.5.1.14. India Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
6.5.1.15. India Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
6.5.1.16. India Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.17. Southeast Asia Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
6.5.1.18. Southeast Asia Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
6.5.1.19. Southeast Asia Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
6.5.1.20. Southeast Asia Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, 2018 - 2031
7.1. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Natural
7.1.1.2. Artificial
7.1.1.3. Nutritive
7.1.1.4. Non- nutritive
7.1.1.5. Polyols
7.1.1.6. Others
7.2. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2018 - 2031
7.2.1.1. Hot Melt Extrusion
7.2.1.2. Microencapsulation
7.2.1.3. Coating
7.2.1.4. Organoleptic Methods
7.2.1.5. Others
7.3. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Solid Dosage Forms
7.3.1.1.1. Tablets
7.3.1.1.2. Granules
7.3.1.1.3. Capsules
7.3.1.2. Liquid Dosage Forms
7.4. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Pharmaceuticals
7.4.1.2. Nutraceuticals
7.4.1.3. Contract Manufacturing Organizations
7.5. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
7.5.1.2. Brazil Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
7.5.1.3. Brazil Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
7.5.1.4. Brazil Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
7.5.1.5. Mexico Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
7.5.1.6. Mexico Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
7.5.1.7. Mexico Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
7.5.1.8. Mexico Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
7.5.1.9. Argentina Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
7.5.1.10. Argentina Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
7.5.1.11. Argentina Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
7.5.1.12. Argentina Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
7.5.1.13. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
7.5.1.14. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
7.5.1.15. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
7.5.1.16. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, 2018 - 2031
8.1. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Natural
8.1.1.2. Artificial
8.1.1.3. Nutritive
8.1.1.4. Non- nutritive
8.1.1.5. Polyols
8.1.1.6. Others
8.2. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hot Melt Extrusion
8.2.1.2. Microencapsulation
8.2.1.3. Coating
8.2.1.4. Organoleptic Methods
8.2.1.5. Others
8.3. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Solid Dosage Forms
8.3.1.1.1. Tablets
8.3.1.1.2. Granules
8.3.1.1.3. Capsules
8.3.1.2. Liquid Dosage Forms
8.4. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Pharmaceuticals
8.4.1.2. Nutraceuticals
8.4.1.3. Contract Manufacturing Organizations
8.5. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
8.5.1.2. GCC Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
8.5.1.3. GCC Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
8.5.1.4. GCC Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.5. South Africa Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
8.5.1.6. South Africa Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
8.5.1.7. South Africa Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
8.5.1.8. South Africa Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.9. Egypt Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
8.5.1.10. Egypt Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
8.5.1.11. Egypt Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
8.5.1.12. Egypt Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.13. Nigeria Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
8.5.1.14. Nigeria Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
8.5.1.15. Nigeria Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
8.5.1.16. Nigeria Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Artery Type vs Indication Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Roquette Frères
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Rochem International, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Gattefose
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Asahi Kasei Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. DuPont de Nemours, Inc
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Cardinal Health Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Dow Pharma Solutions
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. SPI Pharma, Inc
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. GPT Pharmaceuticals Pvt.Ltd
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Adare Pharmaceuticals Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • SPI Pharma, Inc.
  • Adare Pharmaceutical Inc.
  • GPT Pharmaceuticals Pvt. Ltd
  • Roquette Frères
  • Rochem International, Inc.
  • Gattefose
  • Asahi Kasei Corporation
  • DuPont de Nemours, Inc
  • Dow Pharma Solutions

Methodology

Loading
LOADING...